Improve your clinical skills by learning evidence-based ways to treat neurodegenerative diseases including goal writing, adaptive devices, balance training, wheelchair recommendations, energy conservation techniques, fall prevention strategies, and strength and mobility training as well as how to effectively plan for the future.
- CEU DETAILS
How do you define success in treatment of a progressive condition? Neurodegenerative conditions such as Parkinson’s disease, multiple sclerosis, amyotrophic lateral sclerosis, and Huntington’s disease present individuals with new, often worsening, impairments as the conditions progress. While it may come off as a daunting task, rehabilitation professionals play a crucial role in addressing the ‘now’ and preparing for the ‘what if.’
Specific motor impairments, such as freezing of gait in Parkinson’s disease or spasticity in multiple sclerosis, provide unique challenges to mobility and daily activities. Not only are there physical signs we must address in therapy services, but also the non-motor impairments. Oftentimes decreased attention, difficulty multitasking, and behavioral barriers limit our ability to maintain or improve a patient’s functional status.
This course aims to improve clinician skills from diagnosis through late-stage disease management. Literature review, video case studies, and group discussions will be useful in building your skills. Improved understanding of diagnoses, pathologies, and medical management is necessary when considering the clinical decision-making process. This information leads us to define appropriate goals, apply evidence-based interventions, and care for all of the complexities that come along with an uphill battle against neurodegeneration.
At the end of the course, attendees will be able to:
- Summarize fundamentals of pathology associated with PD, secondary parkinsonisms, typicalparkinonisms, MS, ALS, and HD
- Identify clinical signs and symptoms of PD and parkinsonisms, MS, ALS, and HD
a. Describe motor and non-motor signs of PD and parkinsonisms
b. Summarize various cognitive impairments and their impact on functional mobility
- Summarize the mechanism of action, clinical candidacy, and common side effects of disease-specific
medications of PD, MS, ALS, and HD
- Identify appropriate outcome measures related to disease-specific impairments of PD, MS, ALS, and HD
- Apply research-based interventions for PD, MS, ALS, and HD
- Describe long-term management of patients with PD, MS, ALS, and HD through all therapy
services and community-based programs
Robert (Bobby) Hand is a licensed physical therapist currently serving as an outpatient physical therapist at VCU Health. He is a board-certified clinical specialist in neurologic physical therapy and currently working toward his PhD in Health Sciences - Neurologic Rehabilitation through Rocky Mountain University. He is an active member of the American Physical Therapy Association and International Parkinson and Movement Disorder Society. He was the recipient of the 2018 APTA Academy of Neurology Early Career Professional Award and DDSIG Volunteer Award. He is most active in the community through the Parkinson's Foundation, as a past recipient of a Community Grant Award and a participant in the Parkinson's Foundation Physical Therapy Faculty Program 2022 cohort, and CurePSP, where he holds a position on the Board of Directors.
Robert Hand receives an honorarium from Education Resources, Inc.
Robert Hand actively volunteers and associates with the Parkinson's Foundation, CurePSP, and LiftPD
North Hills Hospital
4375 Booth Calloway Road
Medical Office Building Suite 202
North Richland Hills, TX 76180
Hyatt Place - Fort Worth/Hurst
1601 Hurst Town Center Drive
Hurst, TX 76054
This course meets the criteria for 13 contact hours (1.3 CEUs).
Application has been made to the MD and NJ Board of Physical Therapy Examiners.
ERI is an approved agency by the Physical Therapy Board of CA. The DC, DE, PA and VA Boards of Physical Therapy accept other boards' approvals.
TX Physical Therapy Association approved provider.
This course meets the approval for Type 2 CEUs by the TX Board of Occupational Therapy Examiners.
Approved provider of continuing education by the American Occupational Therapy Association #3043, for 13 contact hours - Intermediate Level Occupational Therapy Process: assessment, intervention. The assignment of AOTA CEU's does not imply endorsement of specific course content, products or clinical procedures by AOTA.
This program has been submitted for approval of 13 clock hours of continuing education by the TX Speech-Language-hearing Association (TSHA).
NBCOT Professional Development Provider - 13 PDUs.
This course is offered for up to 1.3 ASHA CEUs (Intermediate level, Professional area).